Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin.

EBioMedicine 2018 Apr 21;30:105-112. Epub 2018 Mar 21.

Dept. of Cancer Biology and Genetics (CBG), The Ohio State University, Columbus, OH, United States. Electronic address:

The World Health Organization has recently introduced molecular prognostic-diagnostic biomarkers in the classification of Central Nervous System (CNS) tumors. In order to characterize subclasses of tumors that cannot find a precise location in the current classification, and, or cannot be tested because of scant material, it is important to find new molecular biomarkers in tissue and, or biological fluid samples. In this study, we identified serum microRNAs that could serve as biomarkers for the diagnosis and prognosis of patients with tumors of glial origin. We retrospectively analyzed microRNA expression in the serum extracellular vesicles of patients with tumors of glial origin. Extracellular vesicles RNA was analyzed by Nanostring. qRT-PCR confirmed 6 overexpressed microRNAs: hsa-miR-4443, hsa-miR-422a, hsa-miR-494-3p, hsa-miR-502-5p, hsa-miR-520f-3p, and hsa-miR-549a. Hsa-miR-4443 was the only microRNA that showed significant differences in most comparisons. In situ hybridization (ISH), confirmed that our signature was mostly expressed in cancer cells. Importantly, hsa-miR-549a and hsa-miR-502-5p expression predicted prognosis in patients with tumors of glial origin. Although more studies are needed, we demonstrated that serum vesicles microRNA profiles are promising diagnostic and prognostic molecular biomarkers that will find an actual application in the clinical practice of CNS tumors.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964183010
Publisher Site
http://dx.doi.org/10.1016/j.ebiom.2018.03.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952410PMC
April 2018
7 Reads

Publication Analysis

Top Keywords

tumors glial
16
patients tumors
16
glial origin
16
molecular biomarkers
8
cns tumors
8
prognosis patients
8
extracellular vesicles
8
tumors
7
micrornas hsa-mir-4443
4
hsa-mir-4443 hsa-mir-422a
4
overexpressed micrornas
4
qrt-pcr confirmed
4
nanostring qrt-pcr
4
hsa-mir-422a hsa-mir-494-3p
4
confirmed overexpressed
4
hsa-mir-502-5p hsa-mir-520f-3p
4
identified serum
4
microrna differences
4
hsa-mir-4443 microrna
4
hsa-mir-549a hsa-mir-4443
4

Similar Publications